Concepts (319)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Hip | 77 | 2022 | 804 | 7.860 |
Why?
|
| Arthroplasty, Replacement, Knee | 54 | 2023 | 632 | 6.480 |
Why?
|
| Prosthesis-Related Infections | 29 | 2023 | 187 | 5.080 |
Why?
|
| Hip Prosthesis | 45 | 2022 | 535 | 5.040 |
Why?
|
| Prosthesis Failure | 39 | 2021 | 520 | 3.840 |
Why?
|
| Acetabulum | 17 | 2020 | 228 | 3.140 |
Why?
|
| Reoperation | 65 | 2023 | 921 | 2.930 |
Why?
|
| Knee Prosthesis | 21 | 2023 | 224 | 2.580 |
Why?
|
| Femur | 22 | 2019 | 375 | 2.480 |
Why?
|
| Prosthesis Design | 26 | 2022 | 483 | 2.410 |
Why?
|
| Arthritis, Infectious | 7 | 2023 | 50 | 1.840 |
Why?
|
| Knee Joint | 22 | 2022 | 760 | 1.600 |
Why?
|
| Aged | 75 | 2023 | 9119 | 1.560 |
Why?
|
| Humans | 129 | 2023 | 27309 | 1.500 |
Why?
|
| Osteolysis | 8 | 2015 | 139 | 1.460 |
Why?
|
| Anti-Bacterial Agents | 9 | 2023 | 380 | 1.420 |
Why?
|
| Middle Aged | 69 | 2022 | 9068 | 1.350 |
Why?
|
| Bone Cements | 7 | 2020 | 85 | 1.300 |
Why?
|
| Postoperative Complications | 17 | 2018 | 930 | 1.290 |
Why?
|
| Retrospective Studies | 48 | 2023 | 3551 | 1.280 |
Why?
|
| Joint Diseases | 6 | 2021 | 116 | 1.260 |
Why?
|
| Male | 79 | 2022 | 14887 | 1.250 |
Why?
|
| Pain, Postoperative | 8 | 2022 | 317 | 1.220 |
Why?
|
| Female | 76 | 2022 | 15334 | 1.210 |
Why?
|
| Aged, 80 and over | 46 | 2022 | 4841 | 1.060 |
Why?
|
| Hip Joint | 14 | 2020 | 556 | 1.020 |
Why?
|
| Radiography | 21 | 2019 | 616 | 0.970 |
Why?
|
| Periprosthetic Fractures | 6 | 2019 | 26 | 0.930 |
Why?
|
| Tibia | 10 | 2021 | 246 | 0.890 |
Why?
|
| Bone Resorption | 5 | 2014 | 83 | 0.830 |
Why?
|
| Vancomycin | 3 | 2018 | 52 | 0.810 |
Why?
|
| Joint Instability | 8 | 2018 | 395 | 0.800 |
Why?
|
| Hip Dislocation | 9 | 2016 | 72 | 0.780 |
Why?
|
| Treatment Outcome | 34 | 2023 | 3540 | 0.720 |
Why?
|
| Pelvic Bones | 3 | 2012 | 18 | 0.710 |
Why?
|
| Tobramycin | 2 | 2018 | 8 | 0.710 |
Why?
|
| Leg Length Inequality | 3 | 2016 | 9 | 0.700 |
Why?
|
| Gentamicins | 2 | 2018 | 20 | 0.700 |
Why?
|
| Synovial Fluid | 11 | 2017 | 92 | 0.690 |
Why?
|
| Tantalum | 8 | 2018 | 27 | 0.690 |
Why?
|
| Arthroplasty, Replacement | 2 | 2016 | 150 | 0.670 |
Why?
|
| Follow-Up Studies | 20 | 2019 | 1807 | 0.620 |
Why?
|
| Adult | 39 | 2022 | 7946 | 0.610 |
Why?
|
| Decision Support Techniques | 2 | 2011 | 47 | 0.590 |
Why?
|
| Radiostereometric Analysis | 1 | 2018 | 7 | 0.580 |
Why?
|
| Incidence | 9 | 2018 | 763 | 0.580 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2016 | 51 | 0.580 |
Why?
|
| Population Surveillance | 2 | 2018 | 115 | 0.570 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 37 | 0.560 |
Why?
|
| Surgical Wound Infection | 2 | 2016 | 87 | 0.550 |
Why?
|
| Osseointegration | 7 | 2016 | 67 | 0.550 |
Why?
|
| Osteotomy | 8 | 2014 | 172 | 0.550 |
Why?
|
| Device Removal | 7 | 2013 | 85 | 0.540 |
Why?
|
| Mupirocin | 1 | 2016 | 17 | 0.510 |
Why?
|
| Bupivacaine | 1 | 2016 | 45 | 0.490 |
Why?
|
| Perioperative Care | 4 | 2017 | 45 | 0.480 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 79 | 0.480 |
Why?
|
| Metal-on-Metal Joint Prostheses | 2 | 2015 | 49 | 0.470 |
Why?
|
| Risk Factors | 12 | 2019 | 2335 | 0.470 |
Why?
|
| Osteoarthritis, Hip | 4 | 2015 | 105 | 0.470 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2016 | 120 | 0.460 |
Why?
|
| Metals | 4 | 2015 | 139 | 0.460 |
Why?
|
| Femur Head | 2 | 2006 | 69 | 0.460 |
Why?
|
| Prospective Studies | 9 | 2019 | 1792 | 0.440 |
Why?
|
| Decision Trees | 2 | 2011 | 14 | 0.430 |
Why?
|
| Medical Device Recalls | 1 | 2013 | 1 | 0.420 |
Why?
|
| Dexamethasone | 1 | 2013 | 34 | 0.410 |
Why?
|
| Polymethyl Methacrylate | 2 | 2011 | 10 | 0.410 |
Why?
|
| Bacteremia | 1 | 2013 | 100 | 0.390 |
Why?
|
| Algorithms | 9 | 2022 | 352 | 0.390 |
Why?
|
| Coated Materials, Biocompatible | 3 | 2014 | 41 | 0.390 |
Why?
|
| Osteoarthritis, Knee | 5 | 2021 | 373 | 0.390 |
Why?
|
| Ketamine | 2 | 2022 | 24 | 0.390 |
Why?
|
| Fractures, Bone | 3 | 2013 | 75 | 0.380 |
Why?
|
| Poisoning | 1 | 2012 | 2 | 0.380 |
Why?
|
| Antirheumatic Agents | 3 | 2017 | 85 | 0.380 |
Why?
|
| Patient Readmission | 1 | 2013 | 130 | 0.380 |
Why?
|
| Skin Diseases | 1 | 2012 | 25 | 0.370 |
Why?
|
| Prostheses and Implants | 2 | 2010 | 154 | 0.360 |
Why?
|
| United States | 14 | 2022 | 2078 | 0.360 |
Why?
|
| Transplantation, Homologous | 7 | 2015 | 279 | 0.340 |
Why?
|
| Patient Satisfaction | 3 | 2019 | 321 | 0.340 |
Why?
|
| Orthopedic Surgeons | 2 | 2022 | 27 | 0.340 |
Why?
|
| Biomechanical Phenomena | 8 | 2021 | 643 | 0.330 |
Why?
|
| Iliac Artery | 1 | 2009 | 5 | 0.320 |
Why?
|
| Demography | 3 | 2019 | 73 | 0.320 |
Why?
|
| Foreign-Body Migration | 1 | 2009 | 19 | 0.310 |
Why?
|
| Quality of Life | 2 | 2011 | 631 | 0.300 |
Why?
|
| Elective Surgical Procedures | 3 | 2018 | 37 | 0.300 |
Why?
|
| Recovery of Function | 8 | 2016 | 303 | 0.290 |
Why?
|
| Bone Transplantation | 4 | 2012 | 203 | 0.290 |
Why?
|
| Time Factors | 10 | 2020 | 1444 | 0.280 |
Why?
|
| Rheumatology | 3 | 2017 | 85 | 0.280 |
Why?
|
| Patient Discharge | 1 | 2009 | 151 | 0.280 |
Why?
|
| Surgeons | 4 | 2022 | 88 | 0.270 |
Why?
|
| Arthroplasty | 3 | 2022 | 159 | 0.260 |
Why?
|
| Therapeutic Irrigation | 4 | 2019 | 57 | 0.260 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2011 | 316 | 0.260 |
Why?
|
| C-Reactive Protein | 7 | 2016 | 97 | 0.240 |
Why?
|
| Salmonella arizonae | 1 | 2005 | 1 | 0.230 |
Why?
|
| Cementation | 1 | 2005 | 32 | 0.230 |
Why?
|
| Occupational Diseases | 1 | 2005 | 23 | 0.230 |
Why?
|
| Equipment Failure Analysis | 3 | 2015 | 98 | 0.220 |
Why?
|
| Risk Assessment | 8 | 2018 | 631 | 0.220 |
Why?
|
| Physical Examination | 4 | 2019 | 118 | 0.210 |
Why?
|
| Debridement | 3 | 2013 | 104 | 0.210 |
Why?
|
| Feasibility Studies | 2 | 2018 | 214 | 0.210 |
Why?
|
| Clinical Competence | 2 | 2019 | 210 | 0.200 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2003 | 3 | 0.200 |
Why?
|
| Blood Sedimentation | 8 | 2016 | 53 | 0.200 |
Why?
|
| Cohort Studies | 7 | 2020 | 1903 | 0.200 |
Why?
|
| Pain Measurement | 4 | 2016 | 486 | 0.200 |
Why?
|
| Preoperative Care | 5 | 2016 | 121 | 0.200 |
Why?
|
| Anesthesia, Conduction | 1 | 2022 | 32 | 0.190 |
Why?
|
| Medicare | 4 | 2013 | 123 | 0.190 |
Why?
|
| Logistic Models | 3 | 2018 | 398 | 0.190 |
Why?
|
| Foreign Bodies | 1 | 2002 | 26 | 0.190 |
Why?
|
| Biocompatible Materials | 3 | 2017 | 89 | 0.190 |
Why?
|
| Femoral Neck Fractures | 1 | 2022 | 10 | 0.190 |
Why?
|
| Porosity | 5 | 2017 | 60 | 0.190 |
Why?
|
| Femoral Fractures | 2 | 2019 | 34 | 0.190 |
Why?
|
| Hemiarthroplasty | 1 | 2022 | 37 | 0.180 |
Why?
|
| Case-Control Studies | 2 | 2018 | 589 | 0.180 |
Why?
|
| Postoperative Period | 3 | 2018 | 334 | 0.180 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 230 | 0.180 |
Why?
|
| Odds Ratio | 2 | 2019 | 277 | 0.170 |
Why?
|
| Leukocyte Count | 7 | 2016 | 63 | 0.170 |
Why?
|
| Bone Nails | 1 | 2020 | 13 | 0.170 |
Why?
|
| Arthrodesis | 1 | 2020 | 39 | 0.170 |
Why?
|
| Prescriptions | 1 | 2020 | 17 | 0.170 |
Why?
|
| Glucocorticoids | 2 | 2017 | 68 | 0.160 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2019 | 8 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 69 | 0.160 |
Why?
|
| Rheumatic Diseases | 2 | 2017 | 53 | 0.160 |
Why?
|
| Illinois | 2 | 2018 | 250 | 0.160 |
Why?
|
| Disease Management | 3 | 2017 | 104 | 0.160 |
Why?
|
| Polyethylene | 2 | 2021 | 124 | 0.150 |
Why?
|
| Treatment Failure | 1 | 2019 | 159 | 0.150 |
Why?
|
| Physician Assistants | 1 | 2019 | 10 | 0.150 |
Why?
|
| Mobile Applications | 1 | 2019 | 29 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 350 | 0.150 |
Why?
|
| Nurse Practitioners | 1 | 2019 | 36 | 0.150 |
Why?
|
| Microspheres | 1 | 2018 | 25 | 0.140 |
Why?
|
| Creatinine | 1 | 2018 | 43 | 0.140 |
Why?
|
| Body Mass Index | 5 | 2020 | 462 | 0.140 |
Why?
|
| Absorption, Physiological | 1 | 2017 | 3 | 0.140 |
Why?
|
| Knee | 1 | 2017 | 45 | 0.140 |
Why?
|
| Range of Motion, Articular | 7 | 2020 | 720 | 0.140 |
Why?
|
| Tendons | 2 | 2012 | 221 | 0.140 |
Why?
|
| Leukocytes | 1 | 2017 | 35 | 0.140 |
Why?
|
| Prosthesis Fitting | 3 | 2011 | 21 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2017 | 258 | 0.130 |
Why?
|
| Allografts | 2 | 2015 | 216 | 0.130 |
Why?
|
| Registries | 3 | 2022 | 201 | 0.130 |
Why?
|
| Povidone-Iodine | 2 | 2019 | 5 | 0.130 |
Why?
|
| Self Concept | 1 | 2016 | 39 | 0.130 |
Why?
|
| Kidney | 1 | 2017 | 152 | 0.130 |
Why?
|
| Biological Products | 1 | 2017 | 43 | 0.130 |
Why?
|
| Methicillin | 1 | 2016 | 7 | 0.130 |
Why?
|
| Liposomes | 1 | 2016 | 13 | 0.130 |
Why?
|
| Orthopedic Procedures | 3 | 2019 | 314 | 0.130 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 29 | 0.130 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 121 | 0.130 |
Why?
|
| Methicillin Resistance | 1 | 2016 | 25 | 0.130 |
Why?
|
| Nasal Cavity | 1 | 2016 | 33 | 0.130 |
Why?
|
| Staphylococcal Infections | 2 | 2016 | 166 | 0.120 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 73 | 0.120 |
Why?
|
| Injections, Intra-Articular | 1 | 2016 | 93 | 0.120 |
Why?
|
| Sleep Wake Disorders | 1 | 2017 | 122 | 0.120 |
Why?
|
| Chlorhexidine | 1 | 2016 | 64 | 0.120 |
Why?
|
| Patella | 2 | 2015 | 72 | 0.120 |
Why?
|
| Prevalence | 3 | 2013 | 458 | 0.120 |
Why?
|
| Cell Count | 1 | 2015 | 81 | 0.120 |
Why?
|
| Ceramics | 1 | 2015 | 20 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 261 | 0.120 |
Why?
|
| Sensitivity and Specificity | 6 | 2015 | 486 | 0.120 |
Why?
|
| Foreign-Body Reaction | 1 | 2015 | 26 | 0.120 |
Why?
|
| Nerve Block | 1 | 2016 | 67 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 177 | 0.120 |
Why?
|
| Intraoperative Complications | 2 | 2013 | 66 | 0.110 |
Why?
|
| Bone Diseases | 2 | 2005 | 24 | 0.110 |
Why?
|
| Sleep | 1 | 2017 | 327 | 0.110 |
Why?
|
| Length of Stay | 2 | 2013 | 321 | 0.110 |
Why?
|
| Observer Variation | 1 | 2014 | 97 | 0.110 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2013 | 16 | 0.110 |
Why?
|
| Decision Making | 2 | 2006 | 220 | 0.100 |
Why?
|
| Insurance, Health | 1 | 2013 | 21 | 0.100 |
Why?
|
| Awards and Prizes | 1 | 2013 | 22 | 0.100 |
Why?
|
| Random Allocation | 1 | 2013 | 123 | 0.100 |
Why?
|
| Surveys and Questionnaires | 4 | 2019 | 1156 | 0.100 |
Why?
|
| Medicaid | 1 | 2013 | 36 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 77 | 0.100 |
Why?
|
| Bone Remodeling | 1 | 2013 | 50 | 0.100 |
Why?
|
| Tibial Fractures | 1 | 2012 | 7 | 0.100 |
Why?
|
| ROC Curve | 4 | 2016 | 141 | 0.100 |
Why?
|
| Heavy Metal Poisoning | 1 | 2012 | 1 | 0.100 |
Why?
|
| Braces | 1 | 2012 | 23 | 0.100 |
Why?
|
| Reimbursement Mechanisms | 1 | 2012 | 9 | 0.090 |
Why?
|
| Serologic Tests | 1 | 2011 | 9 | 0.090 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 478 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 164 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2017 | 258 | 0.080 |
Why?
|
| Suction | 3 | 2015 | 42 | 0.080 |
Why?
|
| Corrosion | 3 | 2015 | 125 | 0.080 |
Why?
|
| Pain Management | 2 | 2022 | 143 | 0.080 |
Why?
|
| Infection Control | 1 | 2011 | 173 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2009 | 24 | 0.080 |
Why?
|
| Sepsis | 1 | 2010 | 115 | 0.080 |
Why?
|
| Anesthesia | 1 | 2009 | 29 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2009 | 69 | 0.070 |
Why?
|
| Preoperative Period | 2 | 2020 | 82 | 0.070 |
Why?
|
| Hip Fractures | 1 | 2008 | 26 | 0.070 |
Why?
|
| Body Weight | 2 | 2019 | 135 | 0.070 |
Why?
|
| Arthritis, Juvenile | 2 | 2017 | 7 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2009 | 119 | 0.070 |
Why?
|
| Piperidines | 2 | 2017 | 12 | 0.070 |
Why?
|
| Biomarkers | 3 | 2017 | 562 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2017 | 24 | 0.070 |
Why?
|
| Arthritis, Psoriatic | 2 | 2017 | 14 | 0.070 |
Why?
|
| Pyrroles | 2 | 2017 | 23 | 0.070 |
Why?
|
| Linear Models | 2 | 2018 | 247 | 0.070 |
Why?
|
| Spondylitis, Ankylosing | 2 | 2017 | 20 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2020 | 425 | 0.070 |
Why?
|
| Age Distribution | 2 | 2005 | 87 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2005 | 77 | 0.060 |
Why?
|
| Guided Tissue Regeneration | 1 | 2006 | 11 | 0.060 |
Why?
|
| Joint Dislocations | 2 | 2018 | 56 | 0.060 |
Why?
|
| Chicago | 3 | 2018 | 953 | 0.060 |
Why?
|
| Surface Properties | 1 | 2006 | 131 | 0.060 |
Why?
|
| Southeastern United States | 1 | 2006 | 14 | 0.060 |
Why?
|
| Neutrophils | 2 | 2017 | 101 | 0.060 |
Why?
|
| Contraindications | 1 | 2006 | 30 | 0.060 |
Why?
|
| Ankle Injuries | 1 | 2005 | 8 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 893 | 0.060 |
Why?
|
| Salmonella Infections | 1 | 2005 | 1 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2005 | 104 | 0.060 |
Why?
|
| Markov Chains | 1 | 2005 | 33 | 0.060 |
Why?
|
| Animal Husbandry | 1 | 2005 | 8 | 0.060 |
Why?
|
| Swine | 1 | 2005 | 73 | 0.060 |
Why?
|
| Graft Survival | 1 | 2005 | 97 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2017 | 190 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2005 | 110 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2005 | 70 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2022 | 352 | 0.050 |
Why?
|
| Chromium | 2 | 2015 | 86 | 0.050 |
Why?
|
| Animals | 3 | 2007 | 3682 | 0.050 |
Why?
|
| Cobalt | 2 | 2015 | 109 | 0.050 |
Why?
|
| Titanium | 2 | 2015 | 169 | 0.050 |
Why?
|
| Hospitalization | 1 | 2005 | 315 | 0.050 |
Why?
|
| Tendon Injuries | 1 | 2005 | 205 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 139 | 0.050 |
Why?
|
| Polyethylenes | 1 | 2002 | 39 | 0.050 |
Why?
|
| Young Adult | 3 | 2014 | 2032 | 0.050 |
Why?
|
| Analgesics | 1 | 2022 | 80 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 126 | 0.050 |
Why?
|
| Comorbidity | 1 | 2003 | 488 | 0.040 |
Why?
|
| Machine Learning | 1 | 2022 | 80 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2003 | 624 | 0.040 |
Why?
|
| Social Class | 1 | 2021 | 64 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 119 | 0.040 |
Why?
|
| Recurrence | 2 | 2011 | 309 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2020 | 46 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 110 | 0.040 |
Why?
|
| Arthritis | 1 | 2020 | 52 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 97 | 0.040 |
Why?
|
| Survivorship | 1 | 2019 | 23 | 0.040 |
Why?
|
| Fracture Fixation, Internal | 1 | 2019 | 59 | 0.040 |
Why?
|
| Patient Selection | 2 | 2012 | 197 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2003 | 335 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 416 | 0.040 |
Why?
|
| Child | 1 | 2003 | 1269 | 0.040 |
Why?
|
| Forecasting | 1 | 2018 | 92 | 0.040 |
Why?
|
| Patient Preference | 1 | 2019 | 35 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 179 | 0.030 |
Why?
|
| Spondylarthritis | 1 | 2017 | 3 | 0.030 |
Why?
|
| Cost Savings | 1 | 2017 | 32 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 350 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 55 | 0.030 |
Why?
|
| Sex Factors | 2 | 2012 | 469 | 0.030 |
Why?
|
| Adolescent | 1 | 2003 | 2185 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 123 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 24 | 0.030 |
Why?
|
| Orthopedics | 1 | 2017 | 113 | 0.030 |
Why?
|
| Joints | 1 | 2016 | 69 | 0.030 |
Why?
|
| Geography | 2 | 2005 | 18 | 0.030 |
Why?
|
| Patellar Ligament | 1 | 2015 | 43 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2014 | 64 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 58 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 92 | 0.030 |
Why?
|
| Anthropometry | 1 | 2012 | 30 | 0.020 |
Why?
|
| California | 1 | 2012 | 36 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 17 | 0.020 |
Why?
|
| Fees and Charges | 1 | 2012 | 4 | 0.020 |
Why?
|
| Causality | 1 | 2011 | 56 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 675 | 0.020 |
Why?
|
| Wound Closure Techniques | 1 | 2011 | 5 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 29 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 180 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 289 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 11 | 0.020 |
Why?
|
| Arthralgia | 1 | 2012 | 135 | 0.020 |
Why?
|
| Analgesia | 1 | 2010 | 38 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 779 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 808 | 0.020 |
Why?
|
| Accidental Falls | 1 | 2010 | 112 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2008 | 42 | 0.020 |
Why?
|
| Fracture Healing | 1 | 2008 | 32 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2007 | 25 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 1108 | 0.020 |
Why?
|
| Materials Testing | 1 | 2007 | 123 | 0.020 |
Why?
|
| Research | 1 | 2006 | 40 | 0.020 |
Why?
|
| Equipment Design | 1 | 2006 | 136 | 0.020 |
Why?
|
| Medicare Part B | 1 | 2005 | 1 | 0.020 |
Why?
|
| Health Services for the Aged | 1 | 2005 | 7 | 0.020 |
Why?
|
| Walking | 1 | 2008 | 253 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 216 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 1380 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 114 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 344 | 0.010 |
Why?
|